Serum protein markers (Hp, GC, C3) in patients with colon cancer.

doi:10.1159/000154117

Back to search

Article

Serum protein markers (Hp, GC, C3) in patients with colon cancer.

Human heredity - 1 Jan 2000

Archimandritis A, Theodoropoulos G, Tryphonos M, Germenis A, Tjivras M, Kalos A, Fertakis A

Abstract excerpt

The phenotypes and gene frequencies of three serum protein systems--Hp, GC and C3--were studied in 184 consecutive patients from all over Greece with colon cancer. Healthy Greeks studied previously in our department served as controls. No significant differences were found between patients and co...

Topics

Adult
Aged
Biomarkers, Tumor
Blood Proteins
Colonic Neoplasms
Female
Gene Frequency
Genetic Markers
Greece
Humans
Male
Middle Aged
Phenotype

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Serum protein markers (Hp, GC, C3) in patients with colon cancer.PMID 8514330Read

Serum protein groups (Hp, GC, C3) in patients with gastric carcinoma.Semantic proximity Read

GC and C3 serum groups in peptic ulcer.Semantic proximity Read

GC and C3 serum groups in ulcerative colitis.Semantic proximity Read

Serum protein polymorphisms in the population of south Yemen.Semantic proximity Read

GC serum groups and otosclerosis.Semantic proximity Read

Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study.Semantic proximity Read

[Colon cancer: molecular markers].Semantic proximity Read

Genetic testing for high-risk colon cancer patients.Semantic proximity Read